DOCSLIB.ORG

Primary Syphilis  Chancroid  Lymphogranuloma Venereum (LGV)  Donovanosis (Granuloma Inguinale)

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Primary Syphilis  Chancroid  Lymphogranuloma Venereum (LGV)  Donovanosis (Granuloma Inguinale) Case 1 34 year old MSM, presented with h/o Genital ulcer of one week duration. Not painful. No discharge 27/01/2017 Sexually Transmitted Infections CMT Ulcerative STIs 2017 Dr.U.Y.Joshi. Consultant in Genitourinary Medicine and HIV Hull and East Yorkshire Case 1 contd Past Medical None significant Past STIs-None Allergic to Penicillin 27/01/2017 Case 1 contd Sexual History LSI 1/7 ago RMP of 3/12 , from Hull, Anal I&R, Oral I&R No condoms 2) 3/52 ago, CMP, ONS, from Leeds, Anal I&R, Oral I & R, No condoms 6 other sexual contacts in last 6/12 (none from abroad) Past H/O STI-none Past Medical –None significent Allergies-None 27/01/2017 Case 1 contd On Genital Examination Solitary ulcer with clear margins and raised edges, slightly tender but quite indurated (rigid edges) Bilateral Inguinal lymph nodes enlarged ,shotty but not tender. Perianal and Anal region- No abnormality detected No obvious skin rash seen 27/01/2017 Differential Diagnosis Herpes simplex Chancroid Trauma Provisional Diagnosis? Primary Chancre (Syphilis) Differential Diagnosis Differential Diagnosis Herpes simplex Chancroid Trauma Causes of Genital Ulcers Genital ulcer Disease(GUD) Sexually Transmitted Non Sexually Transmitted Infective Non Infective Genital Ulceration: Causes of Genital Ulcer/s STI Causes Herpes simplex virus (HSV) Primary Syphilis Chancroid Lymphogranuloma venereum (LGV) Donovanosis (granuloma inguinale) Genital Ulceration: Non STI causes Infective Non-Infective Herpes zoster Behcet’s disease Candidiasis Stevens-Johnson Mycobacterial ulcer Fixed drug eruption Amoebiasis Allergic or irritant contact dermatitis Tularaemia Erosive lichen planus Histoplasmosis Erosive lichen sclerosus Bullous eruption Carcinoma and Intraepithelial neoplasia Trauma e.g. zipper injury Apthosis Others Genital Ulceration: Causes and Investigations Syphilis in men Syphilis in women Usually appears in the: Usually appears in the: Coronal sulcus Vulva Glans Cervix Prepuce Mouth Cervical andAnus anal chancres may not be noticed by patients. There may be regional lymphadenopathy. Co- infection with HIV is common particularly in MSM Mouth Syphilis Caused by Treponema pallidum, a bacterial spirochete. Classically - a painless, indurated ulcer (chancre) with a clear moist base which exudes serum with pressure, seen in approximately 40% of cases. The majority however are non-classical; painful, soft and multiple. 27/01/2017 Primary chancre Cervix 27/01/2017 SYPHILIS (TONGUE) Chancroid 27/01/2017 27/01/2017 Investigations STI screen performed- inc First pass urine for neisseria gonorrhoeae and Chlamydia NAAT Serological tests for syphilis HIV and Hep B serology Swab from the genital lesion for multiplex PCR. ?Dark Field (Ground )Microscopy Dark Field(ground) Microscopy 27/01/2017 Investigations- Dark Field Microscopy(DFM) Use Polymerase Chain Reaction (PCR) (if available) • T. pallidum from the clinical lesion or as part of a multiplex PCR test for: • Herpes simplex virus (HSV) • T pallidum • Haemophilus ducreyi • Chlamydia trachomatis L1,2,3 serovars This is a more sensitive test than DFM but is currently not a Point-of-Care test Investigations -Serology Specific treponemal tests: Cardiolipin tests: Enzyme Immuno Assay (EIA) Rapid plasma reagin (RPR) EIA -IgM Venereal Disease Research Laboratory (VDRL) T. pallidum Particle Agglutination (TPPA) T. pallidum Pointhaemagglutination of care specific treponemal (TPHA) and cardiolipin tests are available but less sensitive than Linestandard Immuno serological Assay tests. (LIA) Investigations Serology Primary Syphilis In primary syphilis, the treponemal serology may intially be negative. The test becomes positive around the end of the first week after appearance of the chancre and it could be any one or a combination of tests If primary syphilis is suspected the EIA, EIA-IgM, TPPA or TPHA and RPR or VDRL should be requested. Investigations-Results Multiplex PCR Treponema pallidum Positive HSV and H.Ducrey-Negative Syphilis serology VDRL Positive 1:16 EIA Positive Serodia Particle -IgM Positive Investigations Results Hepatitis HBsAg –Negative HIV Antigen antibody Duo Test –Reactive Adv repeat STS and HIV serology for confirmation Treatment Treatment Early syphilis Penicillin is the treatment of choice. Other antibiotics can be used as shown in the table. Treatment options First line treatment Benzathine benzylpenicillin IM 2.4 M U X 1 Penicillin allergy Doxycyline 100mg bd PO14/7 Azithromycin 500mgod PO 10/7 Erythromycin 500mg qds PO 14/7 Ceftriaxone 500mg od IM 10/7 (if no anaphylaxis Consider desensitisation of patient if penicillin is required Parental treatment Amoxycillin 500mg tds po +probenecid 500mg qds po 14/7 declined As for penicillin allergy Early Infectious Syphilis Clinical Features of Secondary Syphilis I Clinical features appear 6-8 weeks after appearance of the chancre. Constitutional symptoms - low grade fever, malaise, anorexia and sore throat . Typically patients present with a generalised rash affecting palms and soles. A. The rash can be itchy in about 10% of patients B. Scaly (psoriasiform), annular or hyper or hypopigmented. C. Hypertrophic papules occurring in warm moist areas such as the anus, vulva, medial aspect of thighs, underside of breast and armpits result in flat warty lesions known as condylomata lata. These are the most infectious lesions and are often mistaken for anogenital warts. D. The primary lesion may still be present and should also be looked for. 27/01/2017 HIV Serology Screening test by EIA Antigen/Antibody (Duo) Test. May become reactive by 6 weeks. (Lab still advises to repeat after 3months from the time of the last risk) Confirmation of positive test by Western Blot Method. Offer pretest discussion for high risk clients Diagnosis in HIV-positive persons with Early syphilis More likely to have multiple, large and deep genital ulcers and The risk of neurological complications may be higher with early syphilis. However, the clinical features in HIV-positive and negative individuals with early syphilis are often similar. In a minority of cases, serology may be unreliable: Tendency for the RPR/VDRL titre to be lower in primary and statistically significantly higher in secondary syphilis Although lower or false-negative titres have been reported Syphilis in HIV positive individuals - Treatment Treatment as appropriate for the stage of syphilis infection ie HIV positive individuals to be given same treatment as it is for HIV negative individuals Investigations Serology Secondary and early latent syphilis In secondary and early latent syphilis, all the tests will be positive. EIA is usually the test performed, if positive, it will be confirmed by TPPA or TPHA and at the same time the RPR or VDRL will be performed to assess activity. The Laboratory should be informed of the possibility of secondary syphilis so that the serum is diluted if the cardiolipin test is initially negative. TREATMENT OF EARLY SYPHILIS - PRIMARY, SECONDARY AND EARLY LATENT < 2 YEARS OF ONSET OF INFECTION First Line Regimens for adult males and non- pregnant/non-breastfeeding females Benzathine Penicillin G 2.4 MU IM single dose or Procaine Penicillin G 600,000 units IM daily x 10 days Partner Notification About 50% of sexual partners will be infected. In primary syphilis, sexual partners within the last three months before the chancre appear should be checked and treated. In secondary or early latent syphilis partners in the last two years may need to be checked depending on the sexual history. All partners should be given epidemiological treatment for syphilis at the initial visit as for EIS. Jarisch–Herxheimer Reaction: An acute febrile illness with headache, myalgia, chills andrigours and resolving within 24 hours. Common in early syphilis but is usually not important unless there is neurological or ophthalmic involvement or in pregnancy when it may cause fetal distress and premature labour. Learning Points Be aware of return of Syphilis infection in the developed world. Careful history taking is paramount inc sexual orientation, sexual practices, allergies and past STIs. Under take appropriate clinical examination. Appropriate documentation of clinical findings is critical. 27/01/2017 22 year old female complaining of : Vulval soreness and dysuria – 2 days. Unable to pass water. How would you proceed? History: Noticed sores this morning, extremely painful. Feels unwell and rundown What diagnostic test/s would you carry out? What tests would you carry out? HSV Culture /NAAT Other tests? Treatment Aciclovir -400 mgs 3 times daily for five days Analgesics Herpes Simplex Virus Genital infection What treatment would you offer? Genital Herpes Treatment Aciclovir -400 mgs 3 times daily for five days Analgesics Diagnosis-HSV Viral Culture? NAAT testing HSV Serology? HSV Diagnosis HSV DNA by PCR HSV DNA detection by polymerase chain reaction (PCR) increases HSV detection rates by 11-71% compared with virus culture. PCR-based methods allow less stringent conditions for sample storage and transport than virus culture New real-time PCR assays are rapid and highly specific. Real-time PCR is recommended as the preferred diagnostic method for genital herpes Treatment of Genital Herpes Primary Attack - Oral Therapy superior to topical Aciclovir Dose 200 mgs x 5 x 5 Famciclovir Dose 250 mgs x 3 x 5 Valaciclovir Dose 500 mgs x 2 x 5 Oral Therpay: Speeds the rate of healing Shortens the duration lessens the severity of symptoms decreases the duration of viral shedding Recurrent Genital Herpes Usually of shorter duration and lesser severity May precipitate with physical or mental stress Prodromal symptoms of tingling Usually heal within a week Symptoms more severe in females than males. Psychological impact quite high Recurrent genital herpes Suppressive treatment indicated if Recurrences frequent- 4 or more recurrences per year Affecting sexual relationship/social life Aciclovir 400mgs twice daily for at least 6 months –un interrupted .
Load more

Recommended publications
  • Reporting of Diseases and Conditions Regulation, Amendment, M.R. 289/2014
    THE PUBLIC HEALTH ACT LOI SUR LA SANTÉ PUBLIQUE (C.C.S.M. c. P210) (c. P210 de la C.P.L.M.) Reporting of Diseases and Conditions Règlement modifiant le Règlement sur la Regulation, amendment déclaration de maladies et d'affections Regulation 289/2014 Règlement 289/2014 Registered December 23, 2014 Date d'enregistrement : le 23 décembre 2014 Manitoba Regulation 37/2009 amended Modification du R.M. 37/2009 1 The Reporting of Diseases and 1 Le présent règlement modifie le Conditions Regulation , Manitoba Règlement sur la déclaration de maladies et Regulation 37/2009, is amended by this d'affections , R.M. 37/2009. regulation. 2 Schedules A and B are replaced with 2 Les annexes A et B sont remplacées Schedules A and B to this regulation. par les annexes A et B du présent règlement. Coming into force Entrée en vigueur 3 This regulation comes into force on 3 Le présent règlement entre en vigueur January 1, 2015, or on the day it is registered le 1 er janvier 2015 ou à la date de son under The Statutes and Regulations Act , enregistrement en vertu de Loi sur les textes whichever is later. législatifs et réglementaires , si cette date est postérieure. December 19, 2014 Minister of Health/La ministre de la Santé, 19 décembre 2014 Sharon Blady 1 SCHEDULE A (Section 1) 1 The following diseases are diseases requiring contact notification in accordance with the disease-specific protocol. Common name Scientific or technical name of disease or its infectious agent Chancroid Haemophilus ducreyi Chlamydia Chlamydia trachomatis (including Lymphogranuloma venereum (LGV) serovars) Gonorrhea Neisseria gonorrhoeae HIV Human immunodeficiency virus Syphilis Treponema pallidum subspecies pallidum Tuberculosis Mycobacterium tuberculosis Mycobacterium africanum Mycobacterium canetti Mycobacterium caprae Mycobacterium microti Mycobacterium pinnipedii Mycobacterium bovis (excluding M.
    [Show full text]
  • Syphilis Staging and Treatment Syphilis Is a Sexually Transmitted Disease (STD) Caused by the Treponema Pallidum Bacterium
    Increasing Early Syphilis Cases in Illinois – Syphilis Staging and Treatment Syphilis is a sexually transmitted disease (STD) caused by the Treponema pallidum bacterium. Syphilis can be separated into four different stages: primary, secondary, early latent, and late latent. Ocular and neurologic involvement may occur during any stage of syphilis. During the incubation period (time from exposure to clinical onset) there are no signs or symptoms of syphilis, and the individual is not infectious. Incubation can last from 10 to 90 days with an average incubation period of 21 days. During this period, the serologic testing for syphilis will be non-reactive but known contacts to early syphilis (that have been exposed within the past 90 days) should be preventatively treated. Syphilis Stages Primary 710 (CDC DX Code) Patient is most infectious Chancre (sore) must be present. It is usually marked by the appearance of a single sore, but multiple sores are common. Chancre appears at the spot where syphilis entered the body and is usually firm, round, small, and painless. The chancre lasts three to six weeks and will heal without treatment. Without medical attention the infection progresses to the secondary stage. Secondary 720 Patient is infectious This stage typically begins with a skin rash and mucous membrane lesions. The rash may manifest as rough, red, or reddish brown spots on the palms of the hands, soles of the feet, and/or torso and extremities. The rash does usually does not cause itching. Rashes associated with secondary syphilis can appear as the chancre is healing or several weeks after the chancre has healed.
    [Show full text]
  • Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting As Cellulitis Kelly L
    Lehigh Valley Health Network LVHN Scholarly Works Department of Medicine Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed DO Lehigh Valley Health Network, [email protected] Nektarios I. Lountzis MD Lehigh Valley Health Network, [email protected] Follow this and additional works at: http://scholarlyworks.lvhn.org/medicine Part of the Dermatology Commons, and the Medical Sciences Commons Published In/Presented At Reed, K., Lountzis, N. (2015, April 24). Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis. Poster presented at: Atlantic Dermatological Conference, Philadelphia, PA. This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an authorized administrator. For more information, please contact [email protected]. Disseminated Mycobacterium Tuberculosis with Ulceronecrotic Cutaneous Disease Presenting as Cellulitis Kelly L. Reed, DO and Nektarios Lountzis, MD Lehigh Valley Health Network, Allentown, Pennsylvania Case Presentation: Discussion: Patient: 83 year-old Hispanic female Cutaneous tuberculosis (CTB) was first described in the literature in 1826 by Laennec and has since been History of Present Illness: The patient presented to the hospital for chest pain and shortness of breath and was treated for an NSTEMI. She was noted reported to manifest in a variety of clinical presentations. The most common cause is infection with the to have redness and swelling involving the right lower extremity she admitted to having for 5 months, which had not responded to multiple courses of antibiotics. She acid-fast bacillus Mycobacterium tuberculosis via either primary exogenous inoculation (direct implantation resided in Puerto Rico but recently moved to the area to be closer to her children.
    [Show full text]
  • Pdf/Bookshelf NBK368467.Pdf
    BMJ 2019;365:l4159 doi: 10.1136/bmj.l4159 (Published 28 June 2019) Page 1 of 11 Practice BMJ: first published as 10.1136/bmj.l4159 on 28 June 2019. Downloaded from PRACTICE CLINICAL UPDATES Syphilis OPEN ACCESS Patrick O'Byrne associate professor, nurse practitioner 1 2, Paul MacPherson infectious disease specialist 3 1School of Nursing, University of Ottawa, Ottawa, Ontario K1H 8M5, Canada; 2Sexual Health Clinic, Ottawa Public Health, Ottawa, Ontario K1N 5P9; 3Division of Infectious Diseases, Ottawa Hospital General Campus, Ottawa, Ontario What you need to know Box 1: Symptoms of syphilis by stage of infection (see fig 1) • Incidence rates of syphilis have increased substantially around the Primary world, mostly affecting men who have sex with men and people infected • Symptoms appear 10-90 days (mean 21 days) after exposure with HIV http://www.bmj.com/ • Main symptom is a <2 cm chancre: • Have a high index of suspicion for syphilis in any sexually active patient – Progresses from a macule to papule to ulcer over 7 days with genital lesions or rashes – Painless, solitary, indurated, clean base (98% specific, 31% sensitive) • Primary syphilis classically presents as a single, painless, indurated genital ulcer (chancre), but this presentation is only 31% sensitive; – On glans, corona, labia, fourchette, or perineum lesions can be painful, multiple, and extra-genital – A third are extragenital in men who have sex with men and in women • Diagnosis is usually based on serology, using a combination of treponemal and non-treponemal tests. Syphilis remains sensitive to • Localised painless adenopathy benzathine penicillin G Secondary on 24 September 2021 by guest.
    [Show full text]
  • Nonbacterial Pus-Forming Diseases of the Skin Robert Jackson,* M.D., F.R.C.P[C], Ottawa, Ont
    Nonbacterial pus-forming diseases of the skin Robert Jackson,* m.d., f.r.c.p[c], Ottawa, Ont. Summary: The formation of pus as a Things are not always what they seem Fungus result of an inflammatory response Phaedrus to a bacterial infection is well known. North American blastomycosis, so- Not so well appreciated, however, The purpose of this article is to clarify called deep mycosis, can present with a is the fact that many other nonbacterial the clinical significance of the forma¬ verrucous proliferating and papilloma- agents such as certain fungi, viruses tion of pus in various skin diseases. tous plaque in which can be seen, par- and parasites may provoke pus Usually the presence of pus in or on formation in the skin. Also heat, the skin indicates a bacterial infection. Table I.Causes of nonbacterial topical applications, systemically However, by no means is this always pus-forming skin diseases administered drugs and some injected true. From a diagnostic and therapeutic Fungus materials can do likewise. Numerous point of view it is important that physi¬ skin diseases of unknown etiology cians be aware of the nonbacterial such as pustular acne vulgaris, causes of pus-forming skin diseases. North American blastomycosis pustular psoriasis and pustular A few definitions are required. Pus dermatitis herpetiformis can have is a yellowish [green]-white, opaque, lymphangitic sporotrichosis bacteriologically sterile pustules. The somewhat viscid matter (S.O.E.D.). Pus- cervicofacial actinomycosis importance of considering nonbacterial forming diseases are those in which Intermediate causes of pus-forming conditions of pus can be seen macroscopicaily.
    [Show full text]
  • 2012 Case Definitions Infectious Disease
    Arizona Department of Health Services Case Definitions for Reportable Communicable Morbidities 2012 TABLE OF CONTENTS Definition of Terms Used in Case Classification .......................................................................................................... 6 Definition of Bi-national Case ............................................................................................................................................. 7 ------------------------------------------------------------------------------------------------------- ............................................... 7 AMEBIASIS ............................................................................................................................................................................. 8 ANTHRAX (β) ......................................................................................................................................................................... 9 ASEPTIC MENINGITIS (viral) ......................................................................................................................................... 11 BASIDIOBOLOMYCOSIS ................................................................................................................................................. 12 BOTULISM, FOODBORNE (β) ....................................................................................................................................... 13 BOTULISM, INFANT (β) ...................................................................................................................................................
    [Show full text]
  • Reportable Disease Surveillance in Virginia, 2013
    Reportable Disease Surveillance in Virginia, 2013 Marissa J. Levine, MD, MPH State Health Commissioner Report Production Team: Division of Surveillance and Investigation, Division of Disease Prevention, Division of Environmental Epidemiology, and Division of Immunization Virginia Department of Health Post Office Box 2448 Richmond, Virginia 23218 www.vdh.virginia.gov ACKNOWLEDGEMENT In addition to the employees of the work units listed below, the Office of Epidemiology would like to acknowledge the contributions of all those engaged in disease surveillance and control activities across the state throughout the year. We appreciate the commitment to public health of all epidemiology staff in local and district health departments and the Regional and Central Offices, as well as the conscientious work of nurses, environmental health specialists, infection preventionists, physicians, laboratory staff, and administrators. These persons report or manage disease surveillance data on an ongoing basis and diligently strive to control morbidity in Virginia. This report would not be possible without the efforts of all those who collect and follow up on morbidity reports. Divisions in the Virginia Department of Health Office of Epidemiology Disease Prevention Telephone: 804-864-7964 Environmental Epidemiology Telephone: 804-864-8182 Immunization Telephone: 804-864-8055 Surveillance and Investigation Telephone: 804-864-8141 TABLE OF CONTENTS INTRODUCTION Introduction ......................................................................................................................................1
    [Show full text]
  • 3- Chlamydia, Syphilis & Gonorrhea (STD)
    3- Chlamydia, syphilis & gonorrhea (STD) Microbiology 435’s Teamwork Reproductive Block Learning Objectives: ● Know the causative agents of syphilis, gonorrhea and Chlamydia infections. ● Realize that these three infections are acquired through sexual intercourse. ● Know the pathogenesis of syphilis, gonorrhea and Chlamydia infection. ● Describe the clinical feature of the primary, secondary tertiary syphilis and complications. ● Recall the different diagnostic methods for the different stages of syphilis. ● Describe the clinical features of gonorrhea that affect only men, only women and those ones which affect both sexes. ● Describe the different laboratory tests for the diagnosis of gonorrhea ● Describe the morphology and the distinct life cycle of the Chlamydia. ● Realize what are the different genera, species and serotypes of the family Chlamydophila. ● Recognize that Chlamydia cause different diseases that affect the eye (causing trachoma) and the respiratory system (mainly cause a typical pneumonia). ● Know the different urogenital clinical syndromes caused by Chlamydia trachomatis that affect men, women and both sex. ● Realize that these urogenital syndromes are difficult to differentiate clinically from the similar ones caused by N.gonorrheae. ● Know the treatment of syphilis, gonorrhea and Chlamydia infections. ● Realize that there are no effective vaccines against all these three diseases. Important Resources: 435 females & males slides and ​ ​ ​ Males notes notes, wikipedia, ​ ​ Females notes Lippincott’s Illustrated Reviews: Microbiology- ​ ​ Extra Third Edition ​ ​ Editing file: Here ​ ​ Credit: Team members ​ Introduction (take-home message) ● Syphilis, Chlamydia and Gonorrhea are main STDs, caused by delicate organisms that cannot survive ​ ​ ​ outside the body. Infection may not be localized. ​ ​ ● Clinical presentation may be similar (urethral or genital discharge, ulcers). ● One or more organisms (Bacteria, virus, parasite) may be transmitted by sexual contact.
    [Show full text]
  • Young Adults Young Adults (20 - 35 Years)
    YOUNG ADULTS YOUNG ADULTS (20 - 35 YEARS) A large number of skin diseases reach their peak of expression during the young adult years, and these individuals also represent a large and growing proportion of the South African population, in common with other developing countries. Young adults are especially distressed by skin conditions that are uncomfortable, disfiguring or contagious. This group has also been severely affected by HIV/AIDS, with a consequent increase in the frequency and severity of the HIV- associated dermatoses. Some of these conditions have been discussed in other sections of this review. ACNE KELOIDALIS Inflammatory papules and pustules located mainly on the nape of the neck and occiput characterise this acne-like condition. It primarily affects black males. The lesions heal with scarring, creating huge keloids if this tendency exists. The cause is unknown, and unlikely to result from repeated shaving or short hair cutting. It DENGA A MAKHADO may be caused by unusually thick collagen, which traps and disrupts terminal MB ChB, FCDerm (SA) hair follicles. Treatment is not very successful, and large keloids are best excised Consultant Dermatologist by a surgeon. Mild cases can be helped by intralesional injection of steroids like Division of Dermatology Celestone Soluspan into individual papules and scars. Long-term oral tetracy- clines, as for acne, can also be beneficial, as can topical antibiotics like erythro- University of the Witwatersrand and mycin and clindamycin. Chris Hani Baragwanath Hospital Johannesburg ACNE VULGARIS Denga Anna Makhado is a consultant der- There has been a recent tendency for acne to persist beyond the teens, or even matologist at Chris Hani Baragwanath occur for the first time in adulthood, called persistent adult acne.
    [Show full text]
  • Superimposed Primary Chancre in a Patient with Adamantiades-Behçet's Disease
    124 Sex Transm Inf 1999;75:124–125 Superimposed primary chancre in a patient with Sex Transm Infect: first published as 10.1136/sti.75.2.124 on 1 April 1999. Downloaded from Case report: Adamantiades-Behçet’s disease cobblestone N Meljanac, E Dippel, Ch C Zouboulis Adamantiades-Behçet’s disease was diagnosed in a 42 year old Turkish patient with recurrent oral aphthae, genital ulcerations, papules, and sterile pustules, histologically presenting as cutaneous vasculitis, and intermittent arthritis with joint eVusion particularly of the knees. Six months after initial improvement under treatment with colchicine 2 mg/day, a solitary genital ulcer with enlarged inguinal lymph nodes appeared and persisted for 7 weeks despite the continuation of colchicine treatment and the introduction of clindamycin 2 mg/day intravenously. The unusual persistence of the ulcer and the failure of clindamycin therapy led to further diVerential diagnos- tic considerations and the identification of primary syphilis. The genital lesion healed 4 weeks after initiation of treatment with tetracycline 2 mg/day by mouth for 15 days. (Sex Transm Inf 1999;75:124–125) Keywords: Behçet’s disease; syphilis Case report B51, B18, Bw4, Bw6, and Cw7. Further labo- A 42 year old Turkish man presented on May ratory values were as follows: cardiolipin 1997 at the department of dermatology at the autoantibodies of the IgG type 11.9 anticardio- Free University of Berlin with several 2–10 mm lipin antibodies IgG units/ml (GPL-U/ml) Department of large buccal aphthae, a 2 mm large ulcer at the (normal values <12 GPL-U/ml), of the IgM Dermatology, oreficium urethrae, a 1 cm wide ulcus on the type 3.2 anticardiolipin antibodies IgM University Medical units/ml (MPL-U/ml) (normal <6 MPL-U/ Center Benjamin penile shaft (fig 1a), and papulopustular skin Franklin, The Free lesions at his shoulders and shanks resembling ml), antinuclear antibody titre 1:80, anti- University of Berlin, folliculitis.
    [Show full text]
  • Folliculitis
    Folliculitis Common Cutaneous • Inflammation of hair follicle(s) Bacterial Infections • Symptoms: Often pruritic (itchy) Pseudomonas folliculitis Eosinophilic Folliculitis (HIV) Folliculitis: Causes • Bacteria: – Gram positives (Staph): most common – Gram negatives: Pseudomonas – “hot tub” folliculitis • Fungal: Pityrosporum aka Malassezia • HIV: eosinophilic folliculitis (not bacterial) • Renal Failure: perforating folliculitis (not bacterial) Treatment of Folliculitis 21 year old female with controlled Crohn’s disease and history of • Bacterial hidradenitis suppuritiva presents stating – culture pustule she has recurrent flares of her HS – topical clindamycin or oral cephalexin / doxycycline – shower and change shirt after exercise – keep skin dry; loose clothing • Fungal: topical antifungals (e.g., ketoconazole) • Eosinophilic folliculitis – Phototherapy – Treat the HIV MRSA MRSA Eradication • Swab nares mupirocin ointment bid x 5 days • GI noted Crohn’s was controlled but increased – Swab axillae, perineum, pharynx infliximab intensity, but that was not controlling • Chlorhexidine 4% bodywash qd x 1 week recurrent “flares” • Chlorhexidine mouthwash qd x 1 week; soak toothbrush (or disposable) •I & D MRSA on three occasions • Bleach bath: 1/3 cup to tub, soak x 10 min tiw x 1 week, then prn (perhaps weekly) • THIS WAS INFLIXIMAB-RELATED • Oral antibiotics x 14 days: Bactrim, Doxycycline, depends FURUNCULOSIS FROM MRSA COLONIZATION on sensitivities – D/C infliximab • Swab partners – Anti-MRSA regimen • Hand sanitizer frequently – Patient is better • Bleach wipes to surfaces (doorknobs, faucet handles) • Towels use once then wash; paper towels when possible Pointing abscess (furuncle) --pointing requires I & D-- Acute Paronychia Furuncle Treatment Impetigo • Incise & Drain (I & D) Culture pus • Warm soaks • Antibiotics – e.g., cephalexin orally AND mupirocin topically • If recurrent, suspect nasal carriage of Staph aureus swab culture and mupirocin to nares b.i.d.
    [Show full text]
  • NYS DOH STD Reporting Form
    To order more copies of this form call the Provider Access Line: 1-866-NYC-DOH1 NYC Department of Health & Mental Hygiene Universal Reporting Form PHA No. Form PD-16 (9/09) Mail completed form to: NYC Dept. of Health & Mental Hygiene; 125 Worth Street, Room 315, CN-6; New York, NY 10013 • Or report online: www.nyc.gov/nycmed P Patient Last Name First Name Middle Name DATE OF REPORT A T Patient AKA: Last Name AKA: First Name M.I . I ____ / ____ / ____ E Date of Birth Age Country of Birth Soc.Sec.No. N T ____ / ____ / ________ If patient is a child, Guardian Last Name Guardian First Name M.I. Ⅺ Homeless I Borough: Manhattan N Patient Home Address Apt. No. Zip Code Bronx F Unknown Brooklyn O Home Telephone Number Medical Record Number ( _______ ) ________ – _____________ Queens R Unknown M Staten Island Other Telephone Number Medicaid Number Ⅺ NYC, borough unknown A Unknown ( _______ ) ________ – _____________ Unknown T Ⅺ I Sex Race (Check all that apply) Ethnicity Hispanic Please report non-NYC Not NYC (Specify City/State) Male Transexual Asian White American Indian/Alaska Native Unknown (Check one) Non-Hispanic residents to the appropriate ________________, _____ O N Female Unknown Black Other race Native Hawaiian/Pacific Islander Unknown health jurisdiction Ⅺ Unknown Admitted to hospital? Admission Date Is patient alive? If no, date of death Unknown Is patient pregnant? If yes, due date Yes No ____ / ____ / ________ Unknown Yes No Yes No Unknown Discharge Date Unknown ____ / ____ / ________ Unknown Unknown
    [Show full text]